Compound 1 was found to be a moderate dual AChE/BChE inhibitor and also showed inhibition on self-induced and AChE-induced Aβ aggregation, which established 1 as an interesting marine hit for further anti-AD study. This evidence concerns the gene ACHE and Alzheimer disease.